Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
ANAN | Aquis Stock Exchange
Overview
Corporate Details
- ISIN(s):
- GB00BDQPXQ60
- LEI:
- 894500DFM8VOC5FW4X47
- Country:
- United Kingdom
- Address:
- 6th Floor, 60 Gracechurch Street, EC3V 0HR London
- Website:
- https://www.anandapharma.co.uk/
- Sector:
- Manufacturing
Description
Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 13:25 |
US Cannabis Rescheduling
|
English | 22.4 KB | ||
| 2025-12-12 15:15 |
Result of General Meeting
|
English | 27.2 KB | ||
| 2025-12-03 10:55 |
Redemption of Unsecured CLNs and Director Dealing
|
English | 30.8 KB | ||
| 2025-12-03 08:20 |
CIPN Ethics Approval
|
English | 22.3 KB | ||
| 2025-11-27 08:25 |
Initial Data from Phase 1 Study
|
English | 22.7 KB | ||
| 2025-11-26 08:25 |
Posting of Q&A
|
English | 15.3 KB | ||
| 2025-11-24 08:20 |
Notice of General Meeting and Proposed Delisting
|
English | 29.2 KB | ||
| 2025-11-10 08:20 |
Confirmation of receipt of £168k R&D tax refund
|
English | 23.0 KB | ||
| 2025-10-13 15:45 |
Interims for the six months ended 31 July 2025
|
English | 129.3 KB | ||
| 2025-09-26 12:10 |
Ananda ends UCL/GOSH trials, prioritises MRX1
|
English | 22.6 KB | ||
| 2025-09-16 08:00 |
Ananda attending Cannabinoid Summit
|
English | 22.1 KB | ||
| 2025-08-26 15:43 |
Result of Annual General Meeting
|
English | 29.6 KB | ||
| 2025-08-19 08:00 |
Webinar Presentation Release
|
English | 21.3 KB | ||
| 2025-07-30 14:49 |
Notice of Annual General Meeting
|
English | 21.8 KB | ||
| 2025-07-30 13:44 |
Publication of Annual Report
|
English | 44.2 KB |
Automate Your Workflow. Get a real-time feed of all Ananda Pharma Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ananda Pharma Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ananda Pharma Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
